Ved steady- state var den relative biotilgængelighed for doxazosin fra Doxagamma 4 mg depottabletter og dermed forbundne navne sammenlignet med den umiddelbare frigivelsesform 54% ved 4 mg dosis og 59% ved 8 mg dosis.
At steady-state, the relative bioavailability of doxazosin from Doxagamma 4 mg prolonged release tablets and associated names compared to immediate release form was 54% at the 4 mg dose and 59% at the 8 mg dose.